Biofrontera Inc. (BFRI) Social Stream
BIOFRONTERA INC (BFRI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BFRI.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-25 | 1 | $20 | $20 | $20 | $2.29 | 773.36% |
| 2022-05-25 | 2 | $20 | $11 | $15.5 | $2.29 | 576.86% |
| 2023-01-11 | 2 | $20 | $11.001 | $15.5 | $2.29 | 576.86% |
| 2023-01-31 | 2 | $20 | $7 | $13.5 | $2.29 | 489.52% |
| 2023-05-12 | 2 | $14 | $7 | $10.5 | $2.29 | 358.52% |
| 2023-07-05 | 2 | $280 | $18 | $149 | $2.29 | 6406.55% |
| 2023-11-10 | 2 | $33 | $18 | $25.5 | $2.29 | 1013.54% |
| NA | 1 | $NA | $NA | $NA | $2.29 | NA% |
Price Target Last Issued November 25, 2021
The Trend in the Analyst Price Target
BFRI's average price target has moved up $5.5 over the prior 24 months.
BFRI reports an average of 6,740.86% for its upside potential over the past 40 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-31 | 2 | 20 | 7 | 13.5 | 0.850 | 1488.24% |
| 2023-03-09 | 2 | 14 | 7 | 10.5 | 0.561 | 1771.66% |
| 2023-07-13 | 2 | 33 | 18 | 25.5 | 9.650 | 164.25% |
| 2023-11-07 | 2 | 33 | 18 | 25.5 | 4.200 | 507.14% |
| 2023-11-10 | 2 | 33 | 18 | 25.5 | 3.810 | 569.29% |
BFRI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
BFRI's average broker recommendation rating improved by 0 over the prior 52 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BFRI as an investment opportunity.
- In terms of how BIOFRONTERA INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 19.74% of that group.
- BFRI has a greater upside potential (average analyst target price relative to current price) than 863.68% of all US stocks.
- BIOFRONTERA INC's variance in analysts' estimates is lower than -528.85% of stocks in the micro market cap category.
- In terms of how BIOFRONTERA INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 375.48% of that group.
In the Pharmaceutical Products industry, IOBT, MYNZ, and DERM are the three stocks most similar to BIOFRONTERA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is BFRI a Buy, Hold or Sell? See the POWR Ratings now!